New Study Challenges Leading Explanation for Why Mothers' Type 1 Diabetes Protects Children
Researchers at the University of Colorado Anschutz examined a decades-old puzzle: children of mothers with type 1 diabetes develop the disease at half the rate of children of fathers with it. A genetic explanation alone doesn't hold up.
Evidence label explains the kind of source behind this article (for example peer-reviewed literature vs community video). It is not medical advice.
Key takeaways
- Children whose mothers have type 1 diabetes develop the disease at roughly half the rate of children whose fathers have it—a pattern observed consistently for decades.
- Inherited genetic risk, measured using advanced genetic scoring, does not explain this protective effect.
- A long-standing theory that pregnancy loss of high-risk offspring accounts for the pattern was not supported by the new research.
- The findings suggest other biological mechanisms—beyond genetics—are at work and need further study.
A Puzzle That Has Puzzled Researchers for Decades
For years, scientists have observed something unexpected: children born to mothers with type 1 diabetes are significantly less likely to develop the disease compared to children born to fathers with type 1 diabetes. This protective effect associated with having an affected mother has been documented across multiple studies worldwide, yet the reason remains unclear.
Understanding why this difference exists matters for families planning pregnancies and for researchers trying to understand the biological foundations of type 1 diabetes. If the cause could be identified, it might point to new prevention or management strategies.
Testing a Leading Theory
One explanation that has circulated among researchers for decades centers on pregnancy loss. The theory suggests that pregnancies involving fetuses at highest genetic risk for type 1 diabetes may be more likely to end in miscarriage or stillbirth, particularly when the mother has type 1 diabetes. If this selective loss were occurring, it would mean fewer high-risk children are born to mothers with the disease—potentially explaining the lower rates observed.
To test this theory, researchers at the University of Colorado Anschutz analyzed data from 6,942 children enrolled in The Environmental Determinants of Diabetes in the Young (TEDDY) study, one of the largest prospective cohort studies of type 1 diabetes in the world. Children in the study were followed from infancy into adolescence.
What the Research Found
Using advanced genetic tools, researchers compared the inherited genetic risk for type 1 diabetes across the children in the study, measured through an extended genetic risk score. Their analysis found no significant evidence supporting the pregnancy loss theory. In other words, the inherited genetic risk profiles of children born to mothers with type 1 diabetes did not differ in ways that would suggest selective loss of high-risk pregnancies.
According to Dr. Randi K. Johnson, senior author and an associate professor of biomedical informatics at the CU Anschutz School of Medicine, the findings were clear: "Inherited genetic risk alone does not explain this long-observed maternal effect."
What Comes Next
The study, published in Diabetes Care, does not solve the mystery of the maternal protective effect. Instead, it eliminates one major explanation and points researchers toward other possibilities. Biological mechanisms beyond inherited genetics—such as factors related to pregnancy, the intrauterine environment, or immune system development—may play a role.
The findings underscore how much remains to be learned about type 1 diabetes development and the complex interplay between genes and environment. Future research will likely focus on these alternative biological pathways to explain why children of mothers with type 1 diabetes fare differently from children of fathers with the disease.
Evidence label
Origin: prnewswire.com (News report). Evidence: News report — unverified, pending corroboration. Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
Type1Cure is an information and intelligence hub, not a medical advice service. This article summarizes published research and does not provide diagnosis, treatment, or personal medical guidance. Always talk to your own care team before changing anything about your Type 1 diabetes management.
From Type1Cure
Related reading
More evidence-labeled coverage across the Type1Cure library.
- Research summaryCure & AdvancementsCell Replacement Therapy: A New Frontier in Type 1 Diabetes ResearchVideo report, corroborated with 5 indexed studies
- Research summaryCure & AdvancementsWhy Beta Cells Die in Type 1 Diabetes While Alpha Cells SurviveNews report, corroborated with 2 indexed studies
- Research summaryCure & AdvancementsEarly Trial Shows Some People with Type 1 Diabetes Can Reduce or Stop Insulin—Here's What We KnowNews report, corroborated with 3 indexed studies
- Research summaryCure & AdvancementsBeta Cell Therapy: Moving From Lab Promise to Real-World TreatmentVideo report, corroborated with 2 indexed studies
- Research summaryCure & AdvancementsUnderstanding the Eleodon Trial: What Early Results ShowVideo report — unverified, pending corroboration
- Research summaryCure & AdvancementsIslet Cell Therapies Advance: What You Need to KnowNews report, corroborated with 3 indexed studies